Correlation Between Workiva and Castle Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Workiva and Castle Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Workiva and Castle Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Workiva and Castle Biosciences, you can compare the effects of market volatilities on Workiva and Castle Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Workiva with a short position of Castle Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Workiva and Castle Biosciences.

Diversification Opportunities for Workiva and Castle Biosciences

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Workiva and Castle is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Workiva and Castle Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Castle Biosciences and Workiva is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Workiva are associated (or correlated) with Castle Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Castle Biosciences has no effect on the direction of Workiva i.e., Workiva and Castle Biosciences go up and down completely randomly.

Pair Corralation between Workiva and Castle Biosciences

Allowing for the 90-day total investment horizon Workiva is expected to generate 0.92 times more return on investment than Castle Biosciences. However, Workiva is 1.09 times less risky than Castle Biosciences. It trades about 0.1 of its potential returns per unit of risk. Castle Biosciences is currently generating about 0.08 per unit of risk. If you would invest  6,823  in Workiva on July 4, 2025 and sell it today you would earn a total of  1,785  from holding Workiva or generate 26.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Workiva  vs.  Castle Biosciences

 Performance 
       Timeline  
Workiva 

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Workiva are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile forward-looking signals, Workiva disclosed solid returns over the last few months and may actually be approaching a breakup point.
Castle Biosciences 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Castle Biosciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Castle Biosciences disclosed solid returns over the last few months and may actually be approaching a breakup point.

Workiva and Castle Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Workiva and Castle Biosciences

The main advantage of trading using opposite Workiva and Castle Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Workiva position performs unexpectedly, Castle Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Castle Biosciences will offset losses from the drop in Castle Biosciences' long position.
The idea behind Workiva and Castle Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules